AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

Jan 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-01-03

Reporting Person: Do Hung (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-03	Common Stock	A	29803	$0.00	Acquired	503010	Direct
2018-01-03	Common Stock	F	6239	$15.67	Disposed	496771	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-03	Stock Options (right to buy)	$15.67	A	43075	Acquired	2028-01-03	Common Stock (43075)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 3, 2019. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2019, with the final installment vesting on January 1, 2022.